VELAXFINE XR 37.5

VELAXFINE XR 37.5 is a professionally formulated extended-release tablet that contains Venlafaxine Hydrochloride 37.5 mg, a well-established antidepressant used in the treatment of depression, anxiety disorders, and related mood conditions. Manufactured with precision and quality standards by Steris Healthcare, VELAXFINE XR 37.5 is designed to ensure steady release and absorption of the active compound, improving treatment adherence and minimizing fluctuations in therapeutic effect.

Venlafaxine belongs to the class of serotonin-norepinephrine reuptake inhibitors (SNRIs). It works by increasing the levels of serotonin and norepinephrine—key neurotransmitters involved in mood regulation—thus helping patients feel emotionally stable, less anxious, and more capable of managing daily life.

What is VELAXFINE XR 37.5 used for?

VELAXFINE XR 37.5 is used primarily in the management of major depressive disorder (MDD), generalized anxiety disorder (GAD), panic disorder, and social anxiety disorder. It is often prescribed when SSRIs (selective serotonin reuptake inhibitors) are not effective alone. The extended-release formulation ensures consistent blood levels of the medication, making it suitable for long-term treatment.

Uses of VELAXFINE XR 37.5

This medication is indicated for:

• Major Depressive Disorder (MDD)

• Generalized Anxiety Disorder (GAD)

• Panic Disorder

• Social Anxiety Disorder (SAD)

• Off-label use may include treatment of menopausal hot flashes or neuropathic pain under clinical supervision.

Side Effects of VELAXFINE XR 37.5

Common side effects include nausea, dizziness, dry mouth, insomnia, constipation, and loss of appetite. Some users may also experience increased sweating, abnormal dreams, or fatigue. Serious side effects, though rare, may include elevated blood pressure, serotonin syndrome (when combined with other serotonergic drugs), and suicidal thoughts, especially in young adults. Always report any new or worsening symptoms to your healthcare provider.

Precautions Before Using VELAXFINE XR 37.5

Before starting VELAXFINE XR 37.5, inform your doctor about any history of heart problems, high blood pressure, bipolar disorder, liver or kidney issues, or glaucoma. This medication should not be stopped abruptly; doing so may result in withdrawal symptoms such as agitation, headache, nausea, or confusion. Pregnant and breastfeeding women should use it only if clearly needed and under medical supervision.

Drug Interactions – What drugs interact with VELAXFINE XR 37.5?

VELAXFINE XR 37.5 may interact with the following types of drugs:

• Monoamine oxidase inhibitors (MAOIs): Can cause fatal interactions if taken together. A gap of at least 14 days is required.

• Serotonergic agents: Combining with other antidepressants (like SSRIs, SNRIs, triptans, tramadol) can increase the risk of serotonin syndrome.

• NSAIDs and anticoagulants: May increase the risk of bleeding.

• CYP2D6 inhibitors: Medications such as fluoxetine and paroxetine may affect the metabolism of venlafaxine, increasing the risk of side effects.

• Alcohol: Should be avoided as it may increase drowsiness and impair cognitive functions.

VELAXFINE XR 37.5 offers a clinically effective and balanced option for those seeking long-term relief from anxiety and depression-related disorders. Always take this medication under medical advice and report any unusual effects to your physician for proper management.